It is fair to say that the year 2024 was a 'dramatic' one, in which two major life-threatening epidemics were recorded but safely controlled and key achievements were registered in Rwanda's efforts to ...

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

Nepal has confirmed two additional cases of mpox among migrant workers, according to health authorities on Friday. With the ...

A new laboratory has been created in Wiltshire to boost the UK's ability to fight future pandemics. The Diagnostic ...

Surveillance data from the Centers for Disease Control and Prevention (CDC) indicate a spike in norovirus outbreaks in the ...

The survey of adults in 6 African nations finds 33% are reluctant to receive the mpox vaccine and 39% of parents are ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

Childhood vaccination rates are on the decline at a time when Robert F. Kennedy Jr. could lead the Health and Human Services ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...

TPOXX is approved in the U.S. and Canada for the treatment of smallpox. In the European Union and United Kingdom, marketed as Tecovirimat-SIGA, it is approved for the treatment of smallpox, mpox, ...